Content
10/09/2024
Minneapolis, MN USA
ShiraTronics
completed $66 million Series B Round funding. Investors include
Norwest Venture Partners (lead), Amzak Health, Aperture Venture Partners, Global BioAccess Fund, OSF Ventures, Seroba, Treo Ventures, USVP.
About
ShiraTronics is a forward-thinking medtech startup committed to revolutionizing the field of migraine medicine with our minimally invasive neuromodulation system. Our mission? To transform the lives of those facing Chronic Migraine by reducing headache days and restoring quality of life.
Startup
Sector:
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
